As of 11:59pm ET January 1st, 2014
From the Filings
Dec 31/13 Dec 26/13 Eaton, Mark Price Direct Ownership Common Shares 10 - Acquisition in the public market 188,000 $0.330
Dec 16/13 Dec 16/13 Eaton, Mark Price Direct Ownership Common Shares 10 - Acquisition in the public market 50,000 $0.340
Dec 6/13 Dec 6/13 Diniz, Helio Botelho Direct Ownership Common Shares 10 - Acquisition in the public market 7,000 $0.395
Dec 6/13 Dec 5/13 Diniz, Helio Botelho Direct Ownership Common Shares 10 - Acquisition in the public market 9,000 $0.390
Dec 6/13 Dec 4/13 Diniz, Helio Botelho Direct Ownership Common Shares 10 - Acquisition in the public market 34,000 $0.385
Oct 28/13 Oct 28/13 Eaton, Mark Price Direct Ownership Common Shares 10 - Acquisition in the public market 228,500 $0.450
Oct 15/13 Oct 11/13 Eaton, Mark Price Direct Ownership Common Shares 10 - Acquisition in the public market 24,500 $0.345
Oct 15/13 Oct 11/13 Eaton, Mark Price Direct Ownership Common Shares 10 - Acquisition in the public market 50,000 $0.355
Oct 11/13 Oct 10/13 Hoffman, Michael Direct Ownership Common Shares 10 - Acquisition in the public market 100,000 $0.370
Oct 10/13 Oct 10/13 Eaton, Mark Price Direct Ownership Common Shares 10 - Acquisition in the public market 28,500 $0.375
Oct 10/13 Oct 10/13 Eaton, Mark Price Direct Ownership Common Shares 10 - Acquisition in the public market
Recent BSX News
- Boston Scientific Initiates NAVIGATE-PF Study of the FARAWAVE™ Nav Pulsed Field Ablation Catheter and FARAVIEW™ Software Module • PR Newswire (US) • 04/08/2024 04:00:00 AM
- Boston Scientific Announces Conference Call Discussing First Quarter 2024 Results • PR Newswire (US) • 04/01/2024 12:00:00 PM
- Boston Scientific Receives FDA Approval for the AGENT™ Drug-Coated Balloon • PR Newswire (US) • 03/01/2024 11:55:00 AM
- Boston Scientific Announces Completion of €2.0 Billion Offering of Senior Notes • PR Newswire (US) • 02/27/2024 09:15:00 PM
- Boston Scientific Announces Pricing of €2.0 Billion of Senior Notes • PR Newswire (US) • 02/23/2024 02:27:00 AM
- Boston Scientific to Participate in TD Cowen's 44th Annual Health Care Conference • PR Newswire (US) • 02/05/2024 01:00:00 PM
- Boston Scientific Announces Results for Fourth Quarter and Full Year 2023 • PR Newswire (US) • 01/31/2024 11:30:00 AM
- U.S. Futures Waver Ahead of Fed Decision Amid Mixed Corporate Earnings; Oil Prices Slide • IH Market News • 01/31/2024 11:29:30 AM
- Boston Scientific Receives FDA Approval for FARAPULSE™ Pulsed Field Ablation System • PR Newswire (US) • 01/31/2024 11:25:00 AM
- Rowley Law PLLC is Investigating Proposed Acquisition of Axonics, Inc. • PR Newswire (US) • 01/08/2024 09:55:00 PM
- Axonics Shares Climb 20% After Acquisition by Boston Scientific • Dow Jones News • 01/08/2024 04:36:00 PM
- Boston Scientific To Acquire Axonics For About $3.7 Billion • Dow Jones News • 01/08/2024 12:41:00 PM
- Axonics Announces Definitive Agreement to be Acquired by Boston Scientific • Business Wire • 01/08/2024 12:00:00 PM
- Boston Scientific Announces Agreement to Acquire Axonics, Inc. • PR Newswire (US) • 01/08/2024 12:00:00 PM
- Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 Results • PR Newswire (US) • 01/05/2024 01:00:00 PM
- Boston Scientific Initiates AVANT GUARD Clinical Trial to Evaluate FARAPULSE™ Pulsed Field Ablation System as First-Line Treatment for Persistent Atrial Fibrillation • PR Newswire (US) • 12/28/2023 09:00:00 PM
- Boston Scientific Closes Acquisition of Relievant Medsystems, Inc. • PR Newswire (US) • 11/17/2023 02:00:00 PM
- Boston Scientific to Participate in Stifel's 2023 Healthcare Conference • PR Newswire (US) • 11/01/2023 12:00:00 PM
- BOSTON SCIENTIFIC ANNOUNCES RESULTS FOR THIRD QUARTER 2023 • PR Newswire (US) • 10/26/2023 10:30:00 AM
- Microcap Offers Unique Opportunity for Investors In $10 Billion SCI Industry • AllPennyStocks.com • 10/25/2023 09:18:00 PM
- Boston Scientific Gets Positive Results for Heart-Failure Device • Dow Jones News • 10/25/2023 07:32:00 PM
- Boston Scientific AGENT™ Drug-Coated Balloon Demonstrates Superiority to Uncoated Balloon Angioplasty in the AGENT IDE Trial • PR Newswire (US) • 10/25/2023 06:29:00 PM
- REAL-PE Study Demonstrates Statistically Significant Lower Major Bleeding Rates with the EKOS™ Endovascular System Compared to Mechanical Thrombectomy Device for Treatment of Pulmonary Embolism • PR Newswire (US) • 10/24/2023 07:18:00 PM
- Boston Scientific Down Over 6%, on Pace for Largest Percent Decrease Since May 2022 -- Data Talk • Dow Jones News • 10/11/2023 03:19:00 PM
- Boston Scientific Announces Conference Call Discussing Third Quarter 2023 Results • PR Newswire (US) • 10/02/2023 10:30:00 AM
FEATURED Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • Apr 22, 2024 8:49 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Kona Gold Beverages, Inc. Prepares for First Production Run Set to Launch May 17, 2024 • KGKG • Apr 22, 2024 8:30 AM
VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM